Safety and Feasibility of Argatroban as Anticoagulant in Adults With ECMO
Condition(s):Extracorporeal Membrane Oxygenation Complication; Anticoagulants and Bleeding DisordersLast Updated:January 17, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Extracorporeal Membrane Oxygenation Complication; Anticoagulants and Bleeding DisordersLast Updated:January 17, 2024Recruiting
Condition(s):Respiratory FailureLast Updated:November 9, 2022Recruiting
Condition(s):Stable Coronary Artery Disease (CAD); Unstable Angina (Troponin Negative)Last Updated:March 18, 2024Completed
Condition(s):Heparin-induced ThrombocytopeniaLast Updated:January 11, 2023Completed
Condition(s):Argatroban, Rt-PALast Updated:November 14, 2018Terminated
Condition(s):CVDLast Updated:October 23, 2015Completed
Condition(s):Stroke; Cerebral IschemiaLast Updated:June 21, 2017Completed
Condition(s):Acute Progressive Ischemic StrokeLast Updated:April 19, 2023Completed
Condition(s):StrokeLast Updated:February 22, 2022Completed
Condition(s):Heparin-induced ThrombocytopeniaLast Updated:October 4, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.